| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/26/2010 | US7652135 Compositions useful as inhibitors of protein kinases |
| 01/26/2010 | US7652043 Inhibiting aberrant growth states in cells having Wnt receptors; carcinoma |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652012 2-(R)-(4-fluoro-2-methyl-phenyl)-4-(S)-((8aS)-6-oxo-hexahydro-pyrrolo[1,2-a]-pyrazin-2-yl)-piperidine-1-carboxylic acid [1-(R)-3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide maleate and pharmaceutical compositions thereof |
| 01/26/2010 | US7652007 Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments |
| 01/26/2010 | US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof |
| 01/26/2010 | US7652003 Macrocyclic β-secretase inhibitors |
| 01/26/2010 | CA2555345C Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 01/26/2010 | CA2532437C N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto |
| 01/26/2010 | CA2471651C Amorphous substance of tricyclic triazolobenzazepine derivative |
| 01/26/2010 | CA2447099C Delivery of compounds for the treatment of migraine through an inhalation route |
| 01/26/2010 | CA2403686C Substituted piperidines as melanocortin receptor agonists |
| 01/21/2010 | WO2010009215A1 Nicotinic acid receptor agonist compounds useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009207A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 01/21/2010 | WO2010009196A1 Synthesis of bis-peptides oligomers comprising at least one n-substituted diketopiperazine as structural moiety |
| 01/21/2010 | WO2010009166A1 Oxindolyl inhibitor compounds |
| 01/21/2010 | WO2010009155A2 Fused heterocyclyc inhibitor compounds |
| 01/21/2010 | WO2010008847A2 Pi3k/m tor inhibitors |
| 01/21/2010 | WO2010008828A2 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds |
| 01/21/2010 | WO2010008459A1 Protein kinase inhibitors |
| 01/21/2010 | WO2010008454A1 Protein kinase inhibitors |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007318A2 Novel imidazo[1,2-a]pyrimidine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010007248A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | WO2010007116A2 New chemical compounds |
| 01/21/2010 | WO2010007099A1 2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors |
| 01/21/2010 | WO2010007074A1 Pyrazolo [1, 5-a] pyrimidine derivatives |
| 01/21/2010 | WO2010006970A1 Novel phenylimidazopyrazines |
| 01/21/2010 | WO2010006947A1 Novel phenyl-imidazopyridines and pyridazines |
| 01/21/2010 | WO2010006496A1 Compounds of estrogen-related receptor modulators and the uses thereof |
| 01/21/2010 | WO2009126293A3 Potent chimeric nrti-nnrti bifunctional inhibitors of hiv-1 reverse transcriptase |
| 01/21/2010 | WO2009120660A3 Substituted pyridoxazines |
| 01/21/2010 | WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 01/21/2010 | WO2008116064A3 Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| 01/21/2010 | WO2007041130A3 Deazapurines useful as inhibitors of janus kinases |
| 01/21/2010 | US20100016613 Process for the preparation of a boron-substituted porphyrin |
| 01/21/2010 | US20100016610 Frictionless molecular rotary motors |
| 01/21/2010 | US20100016578 Macrocyclic serine protease inhibitors |
| 01/21/2010 | US20100016545 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement |
| 01/21/2010 | US20100016380 TNF-alpha production inhibitors |
| 01/21/2010 | US20100016330 Novel Derivatives |
| 01/21/2010 | US20100016323 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/21/2010 | US20100016303 Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 01/21/2010 | US20100016302 7-tert-Butyl-3-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-3H-quinazolin-4-one; arthritis; inhibit Btk |
| 01/21/2010 | US20100016301 6-Dimethylamino-2-(2-hydroxymethyl-3-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-imidazo[1,2-b]pyridazin-6-yl }-phenyl)-3,4-dihydro-2H-isoquinolin-1-one; asthma, lupus ; inhibit Btk |
| 01/21/2010 | US20100016293 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use |
| 01/21/2010 | US20100016287 Compounds having affinity for dopamine d3 receptor and uses thereof" |
| 01/21/2010 | US20100016281 Pyrimidine compounds as serotonin receptor modulators |
| 01/21/2010 | US20100016279 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155 |
| 01/21/2010 | US20100016277 Diazabicyclic central nervous system active agents |
| 01/21/2010 | US20100016270 Bridged polycyclic compound based compositions for controlling cholesterol levels |
| 01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 01/21/2010 | US20100016233 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 01/21/2010 | US20100016208 Photoactivatable antimicrobial agents |
| 01/21/2010 | US20100015141 4-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine and n-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 01/21/2010 | US20100013386 Near infrared emitting organic compounds and organic devices using the same |
| 01/21/2010 | CA2739379A1 Compounds as the estrogen-related receptor modulators and the uses thereof |
| 01/21/2010 | CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 01/21/2010 | CA2730610A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 01/21/2010 | CA2730516A1 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | CA2729990A1 New chemical compounds |
| 01/21/2010 | CA2729965A1 Fused heterocyclyc inhibitor compounds |
| 01/21/2010 | CA2728830A1 Protein kinase inhibitors |
| 01/21/2010 | CA2728729A1 Protein kinase inhibitors |
| 01/21/2010 | CA2728228A1 Oxindolyl inhibitor compounds |
| 01/21/2010 | CA2728226A1 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds |
| 01/21/2010 | CA2726460A1 Novel phenyl-imidazopyridines and pyridazines |
| 01/21/2010 | CA2725512A1 Novel phenylimidazopyrazines |
| 01/20/2010 | EP2145888A1 Deazapurine derivatives as HSP90-Inhibitors |
| 01/20/2010 | EP2144881A1 Isoquinolinone derivatives, processes for their preparation and their use in the treatment of chronic obstructive pulmonary disease ( copd ) and asthma |
| 01/20/2010 | EP1615647B1 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/20/2010 | CN101631790A Compounds for the treatment of hepatitis c |
| 01/20/2010 | CN101631789A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 01/20/2010 | CN101628888A Inhibitors of cytosolic phospholipase A2 |
| 01/20/2010 | CN100582109C Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/20/2010 | CN100582108C Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives |
| 01/20/2010 | CN100582107C Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
| 01/19/2010 | US7649091 complex comprising manganese acetate and {[{(Porphine-5,15-diyl)bis[cyclopropyl-diyl]}](2-)-N21,N22,N23, N24 }; reduce damage to cells; preventing or arresting free radical associated diseases or conditions; free radical scavengers |
| 01/19/2010 | US7648975 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 01/19/2010 | US7648841 Comprises metalloporphyrin dimer containing alkaline-earth metal; dichroic spectrophotometry |
| 01/19/2010 | US7648691 Method of fullerene separation and complex containing fullerene |
| 01/19/2010 | CA2466869C Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 01/19/2010 | CA2402751C Decahydro-isoquinolines |
| 01/19/2010 | CA2393466C Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010006130A2 Pde-10 inhibitors |
| 01/14/2010 | WO2010006086A2 Kinase inhibitors and methods of use |
| 01/14/2010 | WO2010005528A2 Pyrrolopyridine carboxylic acid derivatives |
| 01/14/2010 | WO2010005195A2 Method for preparing crystal form l of adefovir dipivoxil |
| 01/14/2010 | WO2009120746A3 Crystalline forms of sitagliptin phosphate |
| 01/14/2010 | WO2009095282A4 Photolatent amidine bases for redox curing of radically curable formulations |
| 01/14/2010 | WO2008083312A3 Chemical linkers and cleavable substrates and conjugates thereof |
| 01/14/2010 | US20100010215 Introverted CB[N] Compounds |
| 01/14/2010 | US20100010214 Lyophilized preparation of 1-methylcarbapenem |
| 01/14/2010 | US20100010063 Heterocyclocarboxamide derivatives |
| 01/14/2010 | US20100010019 Reactive Oxygen Generating Enzyme Inhibitor With Nitric Oxide Bioactivity and Uses Thereof |
| 01/14/2010 | US20100010018 4-Amino-3-Arylamino-6-Arylpyrazolo[3,4-D) Pyrimidine Derivatives, Methods for their Preparation and their Use as Antiviral Agents |
| 01/14/2010 | US20100010016 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | US20100010008 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/14/2010 | US20100009999 Alkyl substituted indoloquinoxalines |